These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9286632)

  • 1. CYP2D6 polymorphism is not associated with essential tremor.
    Agúndez JA; Jiménez-Jiménez FJ; Tejeda R; Ledesma MC; Ortí-Pareja M; Gasalla T; Molina JA; Ruiz J; Coria F; Duarte J; Vázquez A; Ladero JM; Benítez J
    Eur Neurol; 1997; 38(2):99-104. PubMed ID: 9286632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of CYP2D6 allelic variants in multiple sclerosis.
    Agúndez JA; Arroyo R; Ledesma MC; Martínez C; Ladero JM; de Andrés C; Jiménez-Jiménez FJ; Molina JA; Alvarez-Cermeño JC; Varela de Seijas E
    Acta Neurol Scand; 1995 Dec; 92(6):464-7. PubMed ID: 8750111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 polymorphism and Parkinson's disease susceptibility.
    Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice JM; Destée A; Agid Y; Broly F
    Mov Disord; 1999 Mar; 14(2):230-6. PubMed ID: 10091614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.
    Harhangi BS; Oostra BA; Heutink P; van Duijn CM; Hofman A; Breteler MM
    Mov Disord; 2001 Mar; 16(2):290-3. PubMed ID: 11295783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease, CYP2D6 polymorphism, and age.
    Payami H; Lee N; Zareparsi S; Gonzales McNeal M; Camicioli R; Bird TD; Sexton G; Gancher S; Kaye J; Calhoun D; Swanson PD; Nutt J
    Neurology; 2001 May; 56(10):1363-70. PubMed ID: 11376189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease.
    Tsuneoka Y; Matsuo Y; Ichikawa Y; Watanabe Y
    Metabolism; 1998 Jan; 47(1):94-6. PubMed ID: 9440484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the oxidative polymorphism and early onset of Parkinson's disease.
    Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
    Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of CYP2D6 in the Japanese population.
    Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
    Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
    Scordo MG; Dahl ML; Spina E; Cordici F; Arena MG
    Pharmacol Res; 2006 Feb; 53(2):162-5. PubMed ID: 16337409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
    Bon MA; Jansen Steur EN; de Vos RA; Vermes I
    Neurosci Lett; 1999 May; 266(2):149-51. PubMed ID: 10353349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of CYP2D6 in Parkinson's disease.
    Stefanović M; Topić E; Ivanisević AM; Relja M; Korsić M
    Clin Chem Lab Med; 2000 Sep; 38(9):929-34. PubMed ID: 11097352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam.
    Chen X; Xia Y; Gresham LS; Molgaard CA; Thomas RG; Galasko D; Wiederholt WC; Saitoh T
    Neurology; 1996 Sep; 47(3):779-84. PubMed ID: 8797479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
    Ur Rasheed MS; Mishra AK; Singh MP
    Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
    Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA
    Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
    Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
    Ann Neurol; 2004 Mar; 55(3):430-4. PubMed ID: 14991823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease.
    Santt O; Baranova H; Albuisson E; Bignon YJ; Lucotte G
    Eur J Neurol; 2004 Apr; 11(4):247-51. PubMed ID: 15061826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease.
    Tanaka S; Chen X; Xia Y; Kang DE; Matoh N; Sundsmo M; Thomas RG; Katzman R; Thal LJ; Trojanowski JQ; Saitoh T; Ueda K; Masliah E
    Neurology; 1998 Jun; 50(6):1556-62. PubMed ID: 9633694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.